37 completed, 6 withdrawn, 3 terminated, 3 unknown. 50 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 50 | Completed 37, Withdrawn 6, Terminated 3, Unknown 3, Recruiting 1 |
Follow Fibromyalgia: new trials by email Literature Review of Fibromyalgia trials Research Report on Fibromyalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRP vs PRP+Betamethasone vs Betamethasone Injection for Upper Trapezius Myofascial Pain Autologous Platelet-Rich Plasma (PRP), PRP plus Betamethasone, Betamethasone (Diprospan) - Myofascial Pain Dysfunction Syndrome, Trigger Points, Myofascial | Phase 4 | Recruiting | University of Kyrenia | 150 | 2026-05-15 | 2026-06-16 |
| Study on the Efficacy and Safety of Tongluo Kaibi Tablets in the Treatment of Fibromyalgia Syndrome Tongluo Kaibi Tablet, Pregabalin capsule - Fibromyalgia Syndrome | Phase 4 | Completed | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 150 | 2024-01-01 | 2026-07-17 |
| Potential Role of Intravenous Lidocaine Versus Intravenous Ketamine for Pain Management in Fibromyalgia Patients Lidocaine group, Ketamine group, Placebo group - Anesthesia | Phase 4 | Unknown | Ain Shams University | 75 | 2023-09-02 | 2023-12-29 |
| Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome Tongluo-Kaibi tablet plus placebo of pregabalin, placebo of Tongluo-Kaibi tablet plus pregabalin - Fibromyalgia Syndrome | Phase 4 | Unknown | Quan Jiang | 150 | 2023-09-01 | 2023-07-06 |
| Phrenic Nerve Infiltration in Fibromyalgia Bupivacain, Placebo (physiological saline serum infiltration) - Fibromyalgia | Phase 4 | Completed | University of Seville | 60 | 2023-04-03 | 2024-02-28 |
| Medical Cannabis for Treating Pain Related to Fibromyalgia Bedrocan®-type cannabis (22% THC, <1% CBD) - Fibromyalgia | Phase 4 | Completed | Universita degli Studi della Basilicata | 30 | 2021-03-01 | 2023-07-11 |
| Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) microgranules, Placebo microgranules 1800mg, Standard Therapy - Fibromyalgia | Phase 4 | Completed | Epitech Group SpA | 21 | 2020-07-16 | 2023-09-07 |
| Pharmacokinetics of Two Formulation of Pregabalin Pregabalin - Diabetic Peripheral Neuropathy, Fibromyalgia | Phase 4 | Completed | Yung Shin Pharm. Ind. Co., Ltd. | 28 | 2018-01-19 | 2019-01-28 |
| Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain Lidocaine Hydrochloride 2% Intravenous Solution, DIN 02421992 - Chronic Neuropathic Pain and Fibromyalgia | Phase 4 | Completed | Allevio Pain Management Clinic | 162 | 2017-11-05 | 2020-12-04 |
| Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS. D3 Vitamin, Placebo - Fibromyalgia, D Vitamin Deficiency | Phase 4 | Completed | Universidad Autonoma de Nuevo Leon | 80 | 2017-05-31 | 2020-06-17 |
| Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? Low dose naltrexone, Placebo - Fibromyalgia | Phase 4 | Completed | Copenhagen University Hospital, Rigshospitalet | 58 | 2016-06-01 | 2024-02-23 |
| Suvorexant in Insomnia Co-morbid With Fibromyalgia suvorexant, placebo - Insomnia, Fibromyalgia | Phase 4 | Terminated | Henry Ford Health System | 10 | 2016-02-01 | 2021-06-16 |
| Neurologic Signatures of Chronic Pain Disorders flunarizine and/or pregabalin - Chronic Pain, Chronic Migraine | Phase 4 | Completed | Taipei Veterans General Hospital, Taiwan | 200 | 2015-12-01 | 2020-11-02 |
| Discomfort and Psychosocial Difficulties in Fibromyalgia Botox infiltration, Psychology therapy, Botox infiltration & psychology therapy - Fibromyalgia | Phase 4 | Completed | University Rovira i Virgili | 66 | 2012-07-01 | 2014-09-16 |
| Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed Duloxetine - Fibromyalgia | Phase 4 | Withdrawn | University of California, San Diego | 2012-06-01 | 2019-08-09 | |
| The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients Milnacipran - Systemic Lupus Erythematosus, Widespread Pain | Phase 4 | Withdrawn | Loma Linda University | 2011-10-01 | 2015-09-18 | |
| Fibromyalgia of Less Than One Year Duration. Study of Pregabalin Pregabalin - Fibromyalgia | Phase 4 | Withdrawn | Newton-Wellesley Hospital | 2011-09-01 | 2014-04-14 | |
| Effect of Milnacipran on Pain in Fibromyalgia Milnacipram - Fibromyalgia | Phase 4 | Completed | University of California, San Diego | 8 | 2011-02-01 | 2019-09-24 |
| Strengthening Exercises for Fibromyalgia strengthening exercises using a Swiss ball, strengthening exercises - Fibromyalgia | Phase 4 | Completed | Federal University of São Paulo | 60 | 2011-01-01 | 2014-02-14 |
| Influence of Transcranial Direct Current Stimulation of the Primary Motor Cortex on Pain Sensation in Patients Suffering From Fibromyalgia Syndrome transcranial direct current stimulation, sham treatment - Fibromyalgia | Phase 4 | Terminated | Karl Landsteiner Institute of Remobilization and Functional Health | 50 | 2010-12-01 | 2014-07-03 |
Showing 20 of 50. Sign in to see all of them.
Pain (11) · Fatigue (4) · Chronic Pain (3) · Sleep Initiation and Maintenance Disorders (2) · Agnosia (1) · Anemia, Diamond-Blackfan (1) · Epilepsies, Partial (1) · Hemoglobinopathies (1) · Lupus Erythematosus, Systemic (1) · Migraine Disorders (1) · Motor Activity (1) · Myelodysplastic Syndromes (1) · Myofascial Pain Syndromes (1) · Neuralgia (1)
Muscular Diseases (50) · Musculoskeletal Diseases (50) · Nervous System Diseases (50) · Neuromuscular Diseases (50) · Rheumatic Diseases (50) · Pathological Conditions, Signs and Symptoms (17) · Signs and Symptoms (17) · Neurologic Manifestations (16) · Mental Disorders (3) · Pain (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Dyssomnias (2) · Sleep Disorders, Intrinsic (2) · Sleep Wake Disorders (2)
Milnacipran (8) · Pregabalin (8) · Duloxetine Hydrochloride (4) · Quetiapine Fumarate (3) · Acetaminophen (2) · Amitriptyline (2) · Cognitive Behavioral Therapy (2) · Physical Therapy Modalities (2) · Sugars (2) · Betamethasone (1) · Bupivacaine (1) · Cholecalciferol (1) · Deferasirox (1) · Dronabinol (1) · Drug Repositioning (1)
Universidad de Granada (4) · Eli Lilly and Company (3) · Forest Laboratories (2) · Indiana University (2) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2) · State University of New York - Upstate Medical University (2) · University of California, San Diego (2) · Ain Shams University (1) · Albany Medical College (1) · Allevio Pain Management Clinic (1) · Copenhagen University Hospital, Rigshospitalet (1) · Duke University (1) · East Tennessee State University (1) · Epitech Group SpA (1) · Federal University of Espirito Santo (1)
United States (24) · Spain (6) · Mexico (3) · Taiwan (3) · Brazil (2) · Canada (2) · Czechia (2) · India (2) · Italy (2) · Australia (1) · Austria (1) · China (1) · Cyprus (1) · Denmark (1) · Egypt (1)
Elena P Calandre, MD (2) · Allan Spera (1) · Angel Oliva Pascual-Vaca, Dr (1) · Antonio Giardina (1) · Ashwin A Patkar, M.D. (1) · Cesar R. Ramos-Remus, M.D., MSc (1) · Charles E. Argoff, MD (1) · Daniel Clauw, MD (1) · Dawn Marcus, MD (1) · Deborah R. Zucker (1) · Dennis C Ang, MD (1) · Dennis C. Ang, MD (1)
PMID 27475753, PMID 13035388, PMID 14614170, PMID 15818684, PMID 16880448, PMID 17014022, PMID 17123847, PMID 18278830, PMID 18400400, PMID 19365548, PMID 19539427, PMID 19688608, PMID 20074435, PMID 20091598, PMID 20191481, PMID 20461783, PMID 20831796, PMID 20843911, PMID 21390174, PMID 21575194, PMID 21668963, PMID 21686074, PMID 21978149, PMID 22607834, PMID 22753629, PMID 23245607, PMID 23359310, PMID 23432384, PMID 23446065, PMID 23953493, PMID 23983064, PMID 24291734, PMID 24651512, PMID 26414990, PMID 26614719, PMID 26767993, PMID 27537786, PMID 31992394, PMID 33090368, PMID 33982890, PMID 34534180, PMID 35400174, PMID 3553636, PMID 35708466, PMID 37851663, PMID 41214533
2015 (1), R01AR045416 (1), R21AR056046 (1)